DRKS00005412已完成2 期
Diacerein for the treatment of epidermolysis bullosa simplex - Diacerein for EBS-DM
Division of Experimental Dermatology and EB House AustriaDepartment of DermatologyUniversity Hospital SalzburgParacelsus Medical UniversityUniversity Hospital for Dermatology0 个研究点目标入组 17 人开始时间: 2013年11月6日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 17
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 4 Years 至 19 Years（—）
- 性别
- All
入选标准
- •An age between 4 and 19 years
- •- Diagnosis of EBS-DM.
- •- Mutations in the keratin 5 or keratin 14 gene
- •- signed consent form
排除标准
- •- other types of EB with mutations in the keratin 5 or keratin 14 gene.
- •- lack of mutation analysis
- •- Known or expected intolerance to diacerein a component of the cream (e.g. tartrazin) or substances with a similar structure
- •- Pregnancy or lactation
- •- Contemporaneous participation in another clinical trial.
- •- Patients with hepatic dysfunction
- •- Relevant other diseases (e.g. acute infections, ...)
研究者
相似试验
进行中（未招募）
1 期
Diacerein for butterfly childreEpidermolysis bullosa simplex - type Dowling-MearaEUCTR2013-002034-21-ATEB House Austria
进行中（未招募）
不适用
Diacerein for the treatment of atopic dermatitisAtopic dermatitisEUCTR2014-005593-11-ATniversity Hospital of Dermatology, Paracelsus Medical University
Unknown
2 期
Diacerin for the Treatment of Epidermolysis Bullosa SimplexEpidermolysis Bullosa SimplexNCT02470689Tel-Aviv Sourasky Medical Center50
已完成
不适用
Treatment of the skin manifestations of Darier's disease by the topical application of COX-2 inhibitorsDarier's diseaseJPRN-UMIN000015905Department of Dermatology, Keio University School of Medicine10
进行中（未招募）
不适用
BOSENTAN FOR THE TREATMENT OF SKIN ULCERS IN DIABETICMICROANGIOPATHYBosentan for the treatment of skin ulcera in diabetic MicroangiopathyEUCTR2011-001736-30-ATMed. Univ. Wien, Klinik für Dermatologie40